These patients with atopic eczema were matched against children of the same age and sex from the catchment area of the North Manchester Regional Virus Laboratory, who were referred to hospital during the study period and from whom blood was taken to exclude virus infection. The request cards accompanying the blood specimens were examined, and if eczema, herpes simplex, or malignant disease were mentioned the specimen was excluded.
Patients with atopic eczema from the north west of England who attended the department of child health at our hospital were studied. Blood was routinely taken at the first visit from those most severely affected to exclude immune deficiency and to estimate the serum IgE concentration. Serum samples from 121 consecutive patients (81 boys and 40 girls) collected between January 1982 and July 1984 were available for study. No special enquiries were made about a previous history suggestive of herpes simplex infection, but a further five patients from whom blood was taken specifically because of herpes simplex infection were excluded.
These patients with atopic eczema were matched against children of the same age and sex from the catchment area of the North Manchester Regional Virus Laboratory, who were referred to hospital during the study period and from whom blood was taken to exclude virus infection. The request cards accompanying the blood specimens were examined, and if eczema, herpes simplex, or malignant disease were mentioned the specimen was excluded.
Complement dependent serum neutralising antibodies to herpes simplex virus type 1 (strain VR3) were detected by a modification of the microneutralisation test of Pauls and Dowdle.2 Heat inactivated serum samples were tested in quadruplicate at dilutions of 1:5 and 1:10. Any serum that contained neutralising antibodies at a dilution of 1:5 was regarded as seropositive.
Results
The results are summarised in the Table. When findings in children aged 6 months or less were excluded (as their antibodies were probably maternal in origin) 23 of the 113 patients (20%) had antibodies to herpes simplex virus compared with 34 of the 113 controls (30%). The difference between the two groups was insignificant (X2=2-34, p=012).
Patients over the age of 6 months showed a progressive increase in the incidence of antibodies to the virus with age, whereas the increasing incidence with age was less consistent in the control group. group.bmj.com on June 20, 2017 -Published by http://adc.bmj.com/ Downloaded from Serological evidence of herpes simplex virus infection in atopic eczema 417 Discussion As in any hospital based study the patients in this report were selected because their eczema was either unusually severe or particularly refractory to treatment. Such patients are possibly more susceptible to herpes simplex infection than children with milder eczema. The control group was also imperfect in that the controls were not drawn from exactly the same geographical area as the-patients, they were not matched for social class, and some of them possibly had eczema.
The results showed that there was no significant difference between the overall herpes simplex seropositivity rates of the two groups, which were similar to those reported for Edinburgh children in 1967. 3 Our findings suggest that children with atopic eczema are no more likely to acquire herpes simplex infection than normal children. The severity of initial herpes simplex infections in some children with atopic eczema, combined with troublesome recurrent herpes infections in others, may give rise to a false clinical impression of a greater incidence of infection. Our 
